Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine infusion schedule comparison in complex regional pain syndrome
NL-OMON59309Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine in complex regional pain syndrome (CRPS) (2 arms), sponsored by Erasmus MC. Primary endpoint: Pain intensity by Numerical Rating Scale. Started Apr 2024; status: completed.
02
Drugs
esketamine
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on NL-OMON59309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59309.